{"database": "lobbying", "table": "lobbying_activities", "rows": [[3435864, "805baeef-57e9-4b18-a5a4-4cf2a2023a82", "Q3", "ELI LILLY AND COMPANY", 13392, "ELI LILLY AND COMPANY", 2025, "third_quarter", "CSP", "Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value, access and quality", "Commerce, Dept of (DOC),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)", 0, 0, "2025-10-16T10:28:56-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3435864"], "units": {}, "query_ms": 0.42434901115484536, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}